C
COV
CLEO DIAGNOSTICS
0.555
-0.030-5.13%Closed14:59 04/02 AEDT
OPEN/PREV CLOSE0.550/0.550
TODAY RANGE0.520-0.555
VOL175.34K
MARKET CAP74.59M
52 WEEK RANGE0.310-0.900
AVG VOL (3M)364.80K
% TURNOVER0.13%
TURNOVER96.12K
P/E (TTM)-18.2886
% RANGE6.36%
EPS(TTM)-0.0298
P/E(FORWARD)--
P/B8.45
BVPS0.065
DIVIDEND--
P/S59.24
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP45.41M
SHARES OUTSTANDING136.86M
NEXT EARNINGS--
FREE FLOAT83.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·03/30 22:06
Sample Collection Completion for Pivotal US Clinical Trial
ASX·03/22 21:31
CLEO Optimises Biomarker Panel Ahead of FDA Submission
ASX·02/25 05:25
Appendix 4D and Half Yearly Accounts
ASX·02/17 22:46
CLEO Confirms Next-Gen Platform for Ovarian Cancer Test
ASX·01/28 21:27
Quarterly activities and cashflow report
ASX·01/05 04:27
Ceasing to be a substantial holder
ASX·12/29/2025 00:25
Chairman's End of Year Letter to Shareholders
ASX·12/29/2025 00:17
Cleansing Notice
ASX·12/29/2025 00:13
Notification regarding unquoted securities - COV
ASX·12/29/2025 00:05
Application for quotation of securities - COV
ASX·12/17/2025 22:55
Proposed issue of securities - COV
ASX·12/17/2025 22:55
CLEO Raises $5m to Support U.S. Market Launch
ASX·12/16/2025 21:51
Trading Halt
ASX·11/28/2025 05:33
Notice under Listing Rule 3.10A
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others